Argentine full-service law firm Marval, O’Farrell y Mairal has cleared the way for U.S. pharmaceutical group Pfizer to conduct stage-three clinical trials of a potential COVID-19 vaccine in Argentina.

Argentina is among four countries—along with Brazil, Germany and the United States—with sites in the trial. Sites are selected based on factors such as scientific expertise and capabilities and prior experience conducting clinical trials.